These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 1975199)
1. Pharmacological effects and pharmacokinetics of atipamezole, a novel alpha 2-adrenoceptor antagonist--a randomized, double-blind cross-over study in healthy male volunteers. Karhuvaara S; Kallio A; Scheinin M; Anttila M; Salonen JS; Scheinin H Br J Clin Pharmacol; 1990 Jul; 30(1):97-106. PubMed ID: 1975199 [TBL] [Abstract][Full Text] [Related]
2. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers. Scheinin H; Aantaa R; Anttila M; Hakola P; Helminen A; Karhuvaara S Anesthesiology; 1998 Sep; 89(3):574-84. PubMed ID: 9743392 [TBL] [Abstract][Full Text] [Related]
3. Rapid reversal of alpha 2-adrenoceptor agonist effects by atipamezole in human volunteers. Karhuvaara S; Kallio A; Salonen M; Tuominen J; Scheinin M Br J Clin Pharmacol; 1991 Feb; 31(2):160-5. PubMed ID: 1675577 [TBL] [Abstract][Full Text] [Related]
4. Buccal delivery of an alpha 2-adrenergic receptor antagonist, atipamezole, in humans. Huupponen R; Karhuvaara S; Anttila M; Vuorilehto L; Scheinin H Clin Pharmacol Ther; 1995 Nov; 58(5):506-11. PubMed ID: 7586944 [TBL] [Abstract][Full Text] [Related]
5. The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats. Haapalinna A; Leino T; Heinonen E Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):342-51. PubMed ID: 14566451 [TBL] [Abstract][Full Text] [Related]
6. Assessment of MK-912, an alpha 2-adrenoceptor antagonist, with use of intravenous clonidine. Warren JB; Dollery CT; Fuller RW; Williams VC; Gertz BJ Clin Pharmacol Ther; 1989 Jul; 46(1):103-9. PubMed ID: 2568210 [TBL] [Abstract][Full Text] [Related]
7. Sedative and cardiovascular effects of medetomidine, a novel selective alpha 2-adrenoceptor agonist, in healthy volunteers. Scheinin M; Kallio A; Koulu M; Viikari J; Scheinin H Br J Clin Pharmacol; 1987 Oct; 24(4):443-51. PubMed ID: 2891369 [TBL] [Abstract][Full Text] [Related]
8. Effect of medetomidine and its antagonism with atipamezole on stress-related hormones, metabolites, physiologic responses, sedation, and mechanical threshold in goats. Carroll GL; Hartsfield SM; Champney TH; Geller SC; Martinez EA; Haley EL Vet Anaesth Analg; 2005 May; 32(3):147-57. PubMed ID: 15877661 [TBL] [Abstract][Full Text] [Related]
9. A pharmacokinetic study including some relevant clinical effect of medetomidine and atipamezole in lactating dairy cows. Ranheim B; Arnemo JM; Ryeng KA; Søli NE; Horsberg TE J Vet Pharmacol Ther; 1999 Dec; 22(6):368-73. PubMed ID: 10651465 [TBL] [Abstract][Full Text] [Related]
10. Effects of atipamezole--a selective alpha-adrenoceptor antagonist--on cardiac parasympathetic regulation in human subjects. Penttilä J; Kaila T; Helminen A; Anttila M; Karhuvaara S; Huhtala S; Scheinin H Auton Autacoid Pharmacol; 2004 Jul; 24(3):69-75. PubMed ID: 15541014 [TBL] [Abstract][Full Text] [Related]
11. Alpha 2-adrenoceptor-mediated inhibition of gastric acid secretion by medetomidine is efficiently antagonized by atipamezole in rats. Savola M; Savola JM; Puurunen J Arch Int Pharmacodyn Ther; 1989; 301():267-76. PubMed ID: 2576195 [TBL] [Abstract][Full Text] [Related]
12. Reversal of medetomidine-induced sedation in reindeer (Rangifer tarandus tarandus) with atipamezole increases the medetomidine concentration in plasma. Ranheim B; Horsberg TE; Nymoen U; Søli NE; Tyler NJ; Arnemo JM J Vet Pharmacol Ther; 1997 Oct; 20(5):350-4. PubMed ID: 9350254 [TBL] [Abstract][Full Text] [Related]
13. The clinical effectiveness of atipamezole as a medetomidine antagonist in the dog. Vähä-Vahe AT J Vet Pharmacol Ther; 1990 Jun; 13(2):198-205. PubMed ID: 1974650 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist. Pertovaara A; Haapalinna A; Sirviö J; Virtanen R CNS Drug Rev; 2005; 11(3):273-88. PubMed ID: 16389294 [TBL] [Abstract][Full Text] [Related]
15. The role of alpha-2-adrenoceptors in the control of ACTH secretion; interaction with the opioid system. al-Damluji S; Bouloux P; White A; Besser M Neuroendocrinology; 1990 Jan; 51(1):76-81. PubMed ID: 1968233 [TBL] [Abstract][Full Text] [Related]
16. The antagonistic effects of atipamezole and yohimbine on stress-related neurohormonal and metabolic responses induced by medetomidine in dogs. Ambrisko TD; Hikasa Y Can J Vet Res; 2003 Jan; 67(1):64-7. PubMed ID: 12528832 [TBL] [Abstract][Full Text] [Related]
17. Effects of yohimbine, an alpha 2-adrenoceptor antagonist, on experimental neurogenic orthostatic hypotension. Verwaerde P; Tran MA; Montastruc JL; Senard JM; Portolan G Fundam Clin Pharmacol; 1997; 11(6):567-75. PubMed ID: 9444525 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of medetomidine and atipamezole in dairy calves: an agonist-antagonist interaction. Ranheim B; Søli NE; Ryeng KA; Arnemo JM; Horsberg TE J Vet Pharmacol Ther; 1998 Dec; 21(6):428-32. PubMed ID: 9885964 [TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of a benzofuroquinolizine alpha 2-adrenoceptor antagonist. Gertz BJ; Vlasses PH; Rocci ML; Coker LD; Williams V; Bjornsson TD; Jones KH Clin Pharmacol Ther; 1989 Nov; 46(5):566-75. PubMed ID: 2573444 [TBL] [Abstract][Full Text] [Related]
20. Antagonistic effects of atipamezole and yohimbine on xylazine-induced diuresis in healthy dogs. Talukder H; Hikasa Y; Matsuu A; Kawamura H J Vet Med Sci; 2009 May; 71(5):539-48. PubMed ID: 19498277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]